Post by
LongTerm3 on Aug 09, 2023 10:47am
Full Disclosure:
I am longterm on Viemed. My personal feeling is they will beat estimated earnings of 4 cents a share, and do about 43 million in revenue. Y/Y revenue should be up about 27%.
This only includes one month of revenue and earnings from Home Medical Products. The third quater will have the full three months, which would put revenue at about 47 million.
This is just my honest opinion.
Comment by
esifor on Aug 09, 2023 9:42pm
This was a good forecast. Except that their forward-looking is significantly better for next quarter: The Company expects to generate net revenues of approximately $49.0 million to $50.2 million during the third quarter of 2023.